Dec 2023 Articles

Articles
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
Weintraub WS, Bhatt DL, Zhang Z, et al.
Journal:
J Am Heart Assoc

First published: December 29, 2023 DOI: 10.1161/JAHA.123.032413
View
- Share
Articles
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
Tokgözoğlu L, Orringer C, Catapano AL
Journal:
Eur Heart J

First published: December 28, 2023 DOI: 10.1093/eurheartj/ehad837
View
- Share
Articles
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Kastelein JJP, Hsieh A, Dicklin MR, et al.
Journal:
Curr Atheroscler Rep

First published: December 22, 2023 DOI: 10.1007/s11883-023-01184-1
View
- Share
Articles
Omega-3 fatty acids and cardiovascular prevention: is the jury still out?
Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ
Journal:
Intern Med J

First published: December 17, 2023 DOI: 10.1111/imj.16283
View
- Share
Articles
Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa
Al-Ashwal A, Alsagheir A, Al Dubayee M, et al.
Journal:
J Clin Lipidol

First published: December 15, 2023 DOI: 10.1016/j.jacl.2023.12.003
View
- Share
Articles
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
Wright RS, Koenig W, Landmesser U, et al.
Journal:
J Am Coll Cardiol

First published: December 12, 2023 DOI: 10.1016/j.jacc.2023.10.007
View
- Share
Articles
TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk
Nagata JM, Vittinghoff E, Dooley EE, et al.
Journal:
Am J Prev Med

First published: December 10, 2023 DOI: 10.1016/j.amepre.2023.11.004
View
- Share
Articles
Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association
Paluch AE, Boyer WR, Franklin BA, et al.
Journal:
Circulation

First published: December 7, 2023 DOI: 10.1161/CIR.0000000000001189
View
- Share
Articles
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray KK, Nicholls SJ, Li N, et al.
Journal:
Lancet Diabetes Endocrinol

First published: December 4, 2023 DOI: 10.1016/S2213-8587(23)00316-9
View
- Share
Articles
Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study
Tan S, Spear E, Sane N, et al.
Journal:
Heart Lung Circ

First published: December 1, 2023 DOI: 10.1016/j.hlc.2023.10.008
View
- Share
Articles
National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020
Lu Y, Liu Y, Dhingra LS, et al.
Journal:
JAMA Netw Open

First published: December 1, 2023 DOI: 10.1001/jamanetworkopen.2023.45964
View
- Share
Articles
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review
McClintick DJ, Giugliano RP
Journal:
Curr Opin Lipidol

First published: December 1, 2023 DOI: 10.1097/MOL.0000000000000897
View
- Share

Dec 2023 Articles

Articles

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Weintraub WS, Bhatt DL, Zhang Z, et al.

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Articles

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

Kastelein JJP, Hsieh A, Dicklin MR, et al.

Articles

Omega-3 fatty acids and cardiovascular prevention: is the jury still out?

Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ

Articles

Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa

Al-Ashwal A, Alsagheir A, Al Dubayee M, et al.

Articles

Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials

Wright RS, Koenig W, Landmesser U, et al.

Articles

TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk

Nagata JM, Vittinghoff E, Dooley EE, et al.

Articles

Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association

Paluch AE, Boyer WR, Franklin BA, et al.

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Articles

Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study

Tan S, Spear E, Sane N, et al.

Articles

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020

Lu Y, Liu Y, Dhingra LS, et al.

Articles

Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review

McClintick DJ, Giugliano RP

Articles

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Weintraub WS, Bhatt DL, Zhang Z, et al.

Share

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Share

Articles

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

Kastelein JJP, Hsieh A, Dicklin MR, et al.

Share

Articles

Omega-3 fatty acids and cardiovascular prevention: is the jury still out?

Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ

Share

Articles

Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa

Al-Ashwal A, Alsagheir A, Al Dubayee M, et al.

Share

Articles

Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials

Wright RS, Koenig W, Landmesser U, et al.

Share

Articles

TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk

Nagata JM, Vittinghoff E, Dooley EE, et al.

Share

Articles

Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association

Paluch AE, Boyer WR, Franklin BA, et al.

Share

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Share

Articles

Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study

Tan S, Spear E, Sane N, et al.

Share

Articles

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020

Lu Y, Liu Y, Dhingra LS, et al.

Share

Articles

Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review

McClintick DJ, Giugliano RP

Share